Patents by Inventor Michael A. Davitz

Michael A. Davitz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF INCREASING GROWTH OF CORALS USING A BIOCERAMIC
    Publication number: 20230407248
    Abstract: The present disclosure is directed to a method of increasing growth of coral by growing the coral on a bioceramic hydroxyapatite material. An increased growth rate in the coral species is observed with respect to perimeter, surface area and volume as compared with the growth rate on a control material. In some embodiments, the bioceramic hydroxyapatite material contains a carbonatable calcium component with a Ca/P ratio greater than about 1.67.
    Type: Application
    Filed: June 12, 2023
    Publication date: December 21, 2023
    Inventors: Michael A. DAVITZ, William SHEEHAN, Lawrence A. SHIMP, Onno VISSER
  • Decay accelerating factor (DAF) and nucleic acid encoding it
    Patent number: 6632634
    Abstract: Novel fusions of a GPI signal domain and a polypeptide heterologous to the GPI signal domain donor polypeptide are provided for industrial use. Therapeutic administration of the GPI-linked product of the fusions enables the targeting of biological activity to cell membrane surfaces.
    Type: Grant
    Filed: January 27, 1998
    Date of Patent: October 14, 2003
    Assignee: Genentech, Inc.
    Inventors: Ingrid W. Caras, Michael A. Davitz, Victor Nussenzweig, David W. Martin, Jr.
  • Decay accelerating factor (DAF) and nucleic acids encoding it
    Patent number: 5763224
    Abstract: This application relates to nucleic acids encoding decay accelerating factor (hereinafter abbreviated as DAF), as well as vectors and cells which comprise such nucleic acids. Additionally, nucleic acids which encode variants of DAF, such as insertion, deletion or substitution variants, are described. This application also relates to the preparation of DAF in recombinant cell culture. In particular, it is concerned with the large scale manufacture of DAF suitable for pharmaceutical or diagnostic use.
    Type: Grant
    Filed: December 19, 1994
    Date of Patent: June 9, 1998
    Assignees: Genentech, Inc., New York University
    Inventors: Ingrid W. Caras, Michael A. Davitz, Victor Nussenzweig, David W. Martin, Jr.
  • Nucleic acids vectors and cells for the synthesis of membrane anchor fusion polypeptides
    Patent number: 5264357
    Abstract: Novel fusions of a phospholipid anchor domain and a polypeptide heterologous to the anchor domain donor polypeptide are provided for industrial use. Therapeutic administration of the fusions enables the targeting of biological activity to cell membrane surfaces.
    Type: Grant
    Filed: December 19, 1991
    Date of Patent: November 23, 1993
    Assignee: Genentech, Inc.
    Inventors: Ingrid W. Caras, Michael A. Davitz, Victor Nussenzweig, David W. Martin, Jr.
  • Membrane anchor fusion polypeptides
    Patent number: 5109113
    Abstract: Novel fusions of a phospholipid anchor domain and a polypeptide heterologous to the anchor domain donor polypeptide are provided for industrial use. Therapeutic administration of the fusions enables the targeting of biological activity to cell membrane surfaces.
    Type: Grant
    Filed: August 6, 1987
    Date of Patent: April 28, 1992
    Assignees: Genentech, Inc., New York University
    Inventors: Ingrid W. Caras, Michael A. Davitz, Victor Nussenzweig, David W. Martin, Jr.